Schuman ML, Peres Diaz LS, Landa MS, Toblli JE, Cao G, Alvarez AL, Finkielman S, Pirola CJ, García SI. Thyrotropin-releasing hormone overexpression induces structural changes of the left ventricle in the normal rat heart. Am J Physiol Heart Circ Physiol 307: H1667-H1674, 2014. First published October 3, 2014; doi:10.1152/ajpheart.00494.2014.-Thyrotropin-releasing hormone (TRH) hyperactivity has been observed in the left ventricle of spontaneously hypertensive rats. Its long-term inhibition suppresses the development of hypertrophy, specifically preventing fibrosis. The presence of diverse systemic abnormalities in spontaneously hypertensive rat hearts has raised the question of whether specific TRH overexpression might be capable of inducing structural changes in favor of the hypertrophic phenotype in normal rat hearts. We produced TRH overexpression in normal rats by injecting into their left ventricular wall a plasmid driving expression of the preproTRH gene (PCMV-TRH). TRH content and expression of preproTRH, collagen type III, brain natriuretic peptide, -myosin heavy chain, Bax-toBcl-2 ratio, and caspase-3 were measured. The overexpression maneuver was a success, as we found a significant increase in both tripeptide and preproTRH mRNA levels in the PCMV-TRH group compared with the control group. Immunohistochemical staining against TRH showed markedly positive brown signals only in the PCMV-TRH group. TRH overexpression induced a significant increase in fibrosis, evident in the increase of collagen type III expression accompanied by a significant increase in extracellular matrix expansion. We found a significant increase in brain natriuretic peptide and -myosin heavy chain expression (recognized markers of hypertrophy). Moreover, TRH overexpression induced a slight but significant increase in myocyte diameter, indicating the onset of cell hypertrophy. We confirmed the data "in vitro" using primary cardiac cell cultures (fibroblasts and myocytes). In conclusion, these results show that a specific TRH increase in the left ventricle induced structural changes in the normal heart, thus making the cardiac TRH system a promising therapeutic target.heart; rat; thyrotropin-releasing hormone; fibrosis THYROTROPIN-RELEASING HORMONE (TRH), a small neuropeptide (p-Glu-His-Pro-NH 2 ) initially identified in the hypothalamus, is amply distributed in the central nervous system (17) and in other extra neural tissues (4). TRH also acts on the cardiovascular system of rodents, increasing blood pressure, heart rate, and contractility after its intracerebroventricular or intravenous administration (15). The hypertensive effect of TRH seems to be independent from the TRH-thyroid stimulating hormone (TSH)-triiodothyronine (T 3 ) system. In fact, in almost all of our protocols, we measured thyroid hormones [T 3 and thyroxine (T 4 )] and TSH, confirming these results (6). Indeed, other laboratories have demonstrated the existence of different pools of TRH neurons around the central nervous system, indicating that there are many T...